Brief: Unity Biotechnology Announces Exclusive License Agreement With Jocasta Neuroscience To Continue Development Of Α-Klotho Program
20/12/2021 13:23
Dec 20 (Reuters) - UNITY Biotechnology Inc UBX.O :
* UNITY BIOTECHNOLOGY ANNOUNCES EXCLUSIVE LICENSE AGREEMENT
WITH
JOCASTA NEUROSCIENCE TO CONTINUE DEVELOPMENT OF Α-KLOTHO PROGRAM
* UNITY BIOTECHNOLOGY INC - UNITY WILL RECEIVE AN UPFRONT
CASH
PAYMENT FROM JOCASTA
* UNITY BIOTECHNOLOGY - WILL RECEIVE ADDITIONAL PAYMENTS
BASED ON
DEVELOPMENT MILESTONES, APPROVAL MILESTONES, AND SALES-BASED
ROYALTIES, PER INDICATION
Source text for Eikon: ID:nGNXc22cDM
Further company coverage: UBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unity Biotechnology
See all newsU.S. STOCKS ON THE MOVE-Eve Holding, Magnite, EHang Holdings
U.S. STOCKS ON THE MOVE-Lamb Weston, Robinhood, Eve Holding
Unity Biotechnology slips as co faces Nasdaq delisting, plans dissolution
Brief: Unity Biotechnology Inc - Board Approves Plan Of Dissolution - SEC Filing
Brief: UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force